| Year |
Citation |
Score |
| 2020 |
Aboian M, Huang SY, Pampaloni MH, Hawkins RA, Huh Y, Vo K, Gustafson C, Matthay K, Seo Y. I-MIBG PET-CT to monitor metastatic disease in children with relapsed neuroblastoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32414950 DOI: 10.2967/Jnumed.120.243139 |
0.422 |
|
| 2019 |
Seo Y, Huh Y, Huang SY, Hernandez-Pampaloni JM, Hawkins RA, Gustafson WC, Vo KT, Matthay KK. Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for I-MIBG therapy of neuroblastoma using I-MIBG PET/CT. Medical Physics. PMID 30761545 DOI: 10.1002/Mp.13446 |
0.416 |
|
| 2018 |
Ding Y, Sohn JH, Kawczynski MG, Trivedi H, Harnish R, Jenkins NW, Lituiev D, Copeland TP, Aboian MS, Mari Aparici C, Behr SC, Flavell RR, Huang SY, Zalocusky KA, Nardo L, ... ... Hawkins RA, et al. A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using F-FDG PET of the Brain. Radiology. 180958. PMID 30398430 DOI: 10.1148/Radiol.2018180958 |
0.36 |
|
| 2017 |
Behr SC, Bahroos E, Hawkins RA, Nardo L, Ravanfar V, Capbarat EV, Seo Y. Quantitative and Visual Assessments toward Potential Sub-mSv or Ultrafast FDG PET Using High-Sensitivity TOF PET in PET/MRI. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 29192363 DOI: 10.1007/S11307-017-1145-Z |
0.423 |
|
| 2017 |
Behr SC, Mollard BJ, Yang J, Flavell RR, Hawkins RA, Seo Y. Effect of Time-of-Flight and Regularized Reconstructions on Quantitative Measurements and Qualitative Assessments in Newly Diagnosed Prostate Cancer With (18)F-Fluorocholine Dual Time Point PET/MRI. Molecular Imaging. 16: 1536012117736703. PMID 29169313 DOI: 10.1177/1536012117736703 |
0.429 |
|
| 2017 |
Franc BL, Goth S, MacKenzie J, Li X, Blecha J, Lam T, Jivan S, Hawkins RA, VanBrocklin H. In Vivo PET Imaging of the Activated Immune Environment in a Small Animal Model of Inflammatory Arthritis. Molecular Imaging. 16: 1536012117712638. PMID 28625080 DOI: 10.1177/1536012117712638 |
0.328 |
|
| 2017 |
Ronald JA, Kim BS, Gowrishankar G, Namavari M, Alam IS, D'Souza A, Nishikii H, Chuang HY, Ilovich O, Lin CF, Reeves R, Shuhendler A, Hoehne A, Chan CT, Baker J, ... ... Hawkins R, et al. A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant. Cancer Research. 77: 2893-2902. PMID 28572504 DOI: 10.1158/0008-5472.Can-16-2953 |
0.353 |
|
| 2016 |
Barajas RF, Krohn KA, Link JM, Hawkins RA, Clarke JL, Pampaloni MH, Cha S. Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine. Biomedicines. 4. PMID 28536391 DOI: 10.3390/Biomedicines4040024 |
0.438 |
|
| 2016 |
Monteith TS, Kralik SF, Dillon WP, Hawkins RA, Goadsby PJ. The utility of radioisotope cisternography in low CSF/volume syndromes compared to myelography. Cephalalgia : An International Journal of Headache. PMID 26823556 DOI: 10.1177/0333102416628467 |
0.302 |
|
| 2016 |
Flavell RR, Naeger DM, Aparici CM, Hawkins RA, Pampaloni MH, Behr SC. Malignancies with Low Fluorodeoxyglucose Uptake at PET/CT: Pitfalls and Prognostic Importance: Resident and Fellow Education Feature. Radiographics : a Review Publication of the Radiological Society of North America, Inc. 36: 293-4. PMID 26761542 DOI: 10.1148/Rg.2016150073 |
0.422 |
|
| 2016 |
Flavell RR, Naeger DM, Aparici CM, Hawkins RA, Pampaloni MH, Behr SC. Malignancies with low fluoro-deoxyglucose uptake at PET/CT: Pitfalls and prognostic importance Radiographics. 36: 293-294. DOI: 10.1148/Rg.2015150073 |
0.423 |
|
| 2015 |
Trieu M, DuBois SG, Pon E, Nardo L, Hawkins RA, Marachelian A, Twist CJ, Park JR, Matthay KK. Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With (131) I-Metaiodobenzylguanidine (MIBG). Pediatric Blood & Cancer. PMID 26506090 DOI: 10.1002/Pbc.25816 |
0.328 |
|
| 2015 |
Barajas RF, Pampaloni MH, Clarke JL, Seo Y, Savic D, Hawkins RA, Behr SC, Chang SM, Berger M, Dillon WP, Cha S. Assessing Biological Response to Bevacizumab Using 18F-Fluoromisonidazole PET/MR Imaging in a Patient with Recurrent Anaplastic Astrocytoma. Case Reports in Radiology. 2015: 731361. PMID 25793136 DOI: 10.1155/2015/731361 |
0.44 |
|
| 2015 |
Yanik GA, Villablanca JG, Maris JM, Weiss B, Groshen S, Marachelian A, Park JR, Tsao-Wei D, Hawkins R, Shulkin BL, Jackson H, Goodarzian F, Shimada H, Courtier J, Hutchinson R, et al. 131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 673-81. PMID 25639769 DOI: 10.1016/J.Bbmt.2014.12.008 |
0.334 |
|
| 2015 |
Bucknor MD, Rieke V, Seo Y, Horvai AE, Hawkins RA, Majumdar S, Link TM, Saeed M. Bone remodeling after MR imaging-guided high-intensity focused ultrasound ablation: evaluation with MR imaging, CT, Na(18)F-PET, and histopathologic examination in a swine model. Radiology. 274: 387-94. PMID 25302829 DOI: 10.1148/Radiol.14132605 |
0.408 |
|
| 2015 |
Huang SY, Bolch WE, Lee C, Van Brocklin HF, Pampaloni MH, Hawkins RA, Sznewajs A, DuBois SG, Matthay KK, Seo Y. Patient-specific dosimetry using pretherapy [¹²⁴I]m-iodobenzylguanidine ([¹²⁴I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 17: 284-94. PMID 25145966 DOI: 10.1007/S11307-014-0783-7 |
0.328 |
|
| 2014 |
Fidelman N, Kerlan RK, Hawkins RA, Taylor AG, Kohi MP, Kolli KP, Bergsland EK, Kelley RK, Ko AH, Korn WM, McWhirter RM, Luan J, Venook AP. 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study. Journal of Gastrointestinal Cancer. 45: 168-80. PMID 24448917 DOI: 10.1200/Jco.2014.32.3_Suppl.359 |
0.301 |
|
| 2013 |
Bolouri MS, Elias SG, Wisner DJ, Behr SC, Hawkins RA, Suzuki SA, Banfield KS, Joe BN, Hylton NM. Triple-negative and non-triple-negative invasive breast cancer: association between MR and fluorine 18 fluorodeoxyglucose PET imaging. Radiology. 269: 354-61. PMID 23878283 DOI: 10.1148/Radiol.13130058 |
0.328 |
|
| 2013 |
French S, DuBois SG, Horn B, Granger M, Hawkins R, Pass A, Plummer E, Matthay K. 131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma. Pediatric Blood & Cancer. 60: 879-84. PMID 23024113 DOI: 10.1002/Pbc.24351 |
0.315 |
|
| 2013 |
Aparici CM, Hawkins RA. PET/CT Abdominal Imaging. 751-758. DOI: 10.1007/978-3-642-13327-5_152 |
0.304 |
|
| 2012 |
Matthay KK, Weiss B, Villablanca JG, Maris JM, Yanik GA, Dubois SG, Stubbs J, Groshen S, Tsao-Wei D, Hawkins R, Jackson H, Goodarzian F, Daldrup-Link H, Panigrahy A, Towbin A, et al. Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1155-63. PMID 22700000 DOI: 10.2967/Jnumed.111.098624 |
0.338 |
|
| 2012 |
DuBois SG, Chesler L, Groshen S, Hawkins R, Goodarzian F, Shimada H, Yanik G, Tagen M, Stewart C, Mosse YP, Maris JM, Tsao-Wei D, Marachelian A, Villablanca JG, Matthay KK. Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 2679-86. PMID 22421195 DOI: 10.1158/1078-0432.Ccr-11-3201 |
0.315 |
|
| 2012 |
Gawande RS, Khurana A, Messing S, Zhang D, Castañeda RT, Goldsby RE, Hawkins RA, Daldrup-Link HE. Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET/CT. Radiology. 262: 613-22. PMID 22157202 DOI: 10.1148/Radiol.11110715 |
0.397 |
|
| 2011 |
Kumar R, Hawkins RA, Yeh BM, Wang ZJ. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant? Nuclear Medicine Communications. 32: 802-7. PMID 21685821 DOI: 10.1097/Mnm.0B013E3283483E04 |
0.416 |
|
| 2010 |
Lee CL, Wahnishe H, Sayre GA, Cho HM, Kim HJ, Hernandez-Pampaloni M, Hawkins RA, Dannoon SF, VanBrocklin HF, Itsara M, Weiss WA, Yang X, Haas-Kogan DA, Matthay KK, Seo Y. Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET. Medical Physics. 37: 4861-7. PMID 20964203 DOI: 10.1118/1.3480965 |
0.403 |
|
| 2010 |
Seo Y, Aparici CM, Cooperberg MR, Konety BR, Hawkins RA. In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CT. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 31-6. PMID 20008977 DOI: 10.2967/Jnumed.109.067108 |
0.352 |
|
| 2009 |
Kleis MA, Daldrup-Link H, Goldsby R, Hawkins RA, Franc BL. Multiple Scalp Lesions in a Patient with Keratitis, Ichthyosis and Deafness Syndrome Mimicking Metastatic Squamous Cell Carcinoma on 18F-FDG PET/CT. Radiology Case Reports. 4: 218. PMID 27307799 DOI: 10.2484/Rcr.V4I2.218 |
0.38 |
|
| 2009 |
Taggart DR, Han MM, Quach A, Groshen S, Ye W, Villablanca JG, Jackson HA, Mari Aparici C, Carlson D, Maris J, Hawkins R, Matthay KK. Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5343-9. PMID 19805691 DOI: 10.1200/Jco.2008.20.5732 |
0.456 |
|
| 2009 |
Kebebew E, Lindsay S, Clark OH, Woeber KA, Hawkins R, Greenspan FS. Results of rosiglitazone therapy in patients with thyroglobulin-positive and radioiodine-negative advanced differentiated thyroid cancer. Thyroid : Official Journal of the American Thyroid Association. 19: 953-6. PMID 19678746 DOI: 10.1089/Thy.2008.0371 |
0.346 |
|
| 2009 |
Gonias S, Goldsby R, Matthay KK, Hawkins R, Price D, Huberty J, Damon L, Linker C, Sznewajs A, Shiboski S, Fitzgerald P. Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma Journal of Clinical Oncology. 27: 4162-4168. PMID 19636009 DOI: 10.1200/Jco.2008.21.3496 |
0.368 |
|
| 2009 |
Matthay KK, Quach A, Huberty J, Franc BL, Hawkins RA, Jackson H, Groshen S, Shusterman S, Yanik G, Veatch J, Brophy P, Villablanca JG, Maris JM. Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 1020-5. PMID 19171714 DOI: 10.1200/Jco.2007.15.7628 |
0.321 |
|
| 2009 |
Kleis M, Daldrup-Link H, Matthay K, Goldsby R, Lu Y, Schuster T, Schreck C, Chu PW, Hawkins RA, Franc BL. Diagnostic value of PET/CT for the staging and restaging of pediatric tumors. European Journal of Nuclear Medicine and Molecular Imaging. 36: 23-36. PMID 18719909 DOI: 10.1007/S00259-008-0911-1 |
0.406 |
|
| 2008 |
Badiee S, Franc BL, Webb EM, Chu B, Hawkins RA, Coakley F, Singer L. Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases. Ajr. American Journal of Roentgenology. 191: 1436-9. PMID 18941082 DOI: 10.2214/Ajr.07.3750 |
0.404 |
|
| 2008 |
Daldrup-Link HE, Hawkins RA, Meier R, Goldsby RE, Artemov D. Receptor imaging of pediatric tumors: clinical practice and new developments. Pediatric Radiology. 38: 1154-61. PMID 18483730 DOI: 10.1007/S00247-008-0878-X |
0.3 |
|
| 2008 |
Lee TJ, Glastonbury CM, Buckley AF, Eisele DW, Hawkins RA. Perineural spread of melanoma demonstrated by F-18 FDG PET With MRI and pathologic correlation. Clinical Nuclear Medicine. 33: 106-8. PMID 18209529 DOI: 10.1097/Rlu.0B013E31815Ef7Be |
0.408 |
|
| 2008 |
Kleis M, Daldrup-Link HE, Matthay KK, Goldsby RE, Rummeny EJ, Schuster T, Hawkins RA, Franc BL. PET/CT Staging und Restaging maligner Tumore bei Kindern und Jugendlichen Rofo-Fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren. 180. DOI: 10.1055/S-2008-1073977 |
0.381 |
|
| 2007 |
Franc BL, Hawkins RA. Positron emission tomography, positron emission tomography-computed tomography, and molecular imaging of the breast cancer patient. Seminars in Roentgenology. 42: 265-79. PMID 17919529 DOI: 10.1053/J.Ro.2007.06.005 |
0.374 |
|
| 2007 |
Purcell DD, Coakley FV, Franc BL, Hawkins RA, Boddington SE, Yeh BM. Anterior layering of excreted 18F-FDG in the bladder on PET/CT: frequency and cause. Ajr. American Journal of Roentgenology. 189: W96-9. PMID 17646448 DOI: 10.2214/Ajr.07.2175 |
0.381 |
|
| 2007 |
Teo BK, Seo Y, Bacharach SL, Carrasquillo JA, Libutti SK, Shukla H, Hasegawa BH, Hawkins RA, Franc BL. Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 802-10. PMID 17475970 DOI: 10.2967/Jnumed.106.035576 |
0.367 |
|
| 2007 |
Falk MS, Truitt AK, Coakley FV, Kashani-Sabet M, Hawkins RA, Franc B. Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma. Nuclear Medicine Communications. 28: 273-80. PMID 17325590 DOI: 10.1097/Mnm.0B013E3280708Ecf |
0.398 |
|
| 2006 |
Fitzgerald PA, Goldsby RE, Huberty JP, Price DC, Hawkins RA, Veatch JJ, Dela Cruz F, Jahan TM, Linker CA, Damon L, Matthay KK. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG). Annals of the New York Academy of Sciences. 1073: 465-90. PMID 17102115 DOI: 10.1196/Annals.1353.050 |
0.335 |
|
| 2006 |
Seo Y, Franc BL, Hawkins RA, Wong KH, Hasegawa BH. Progress in SPECT/CT imaging of prostate cancer. Technology in Cancer Research & Treatment. 5: 329-36. PMID 16866563 DOI: 10.1177/153303460600500404 |
0.368 |
|
| 2006 |
Messina JA, Cheng SC, Franc BL, Charron M, Shulkin B, To B, Maris JM, Yanik G, Hawkins RA, Matthay KK. Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma. Pediatric Blood & Cancer. 47: 865-74. PMID 16444675 DOI: 10.1002/Pbc.20777 |
0.319 |
|
| 2005 |
Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R. Value of FDG PET in the assessment of patients with multiple myeloma. American Journal of Roentgenology. 184: 1199-1204. PMID 15788594 DOI: 10.2214/Ajr.184.4.01841199 |
0.451 |
|
| 2005 |
Seo Y, Kurhanewicz J, Franc BL, Hawkins RA, Hasegawa BH. Improved prostate cancer imaging with SPECT/CT and MRI/MRSI Ieee Transactions On Nuclear Science. 52: 1316-1320. DOI: 10.1109/Tns.2005.858241 |
0.375 |
|
| 2004 |
Wang ZJ, Reddy GP, Gotway MB, Higgins CB, Jablons DM, Ramaswamy M, Hawkins RA, Webb WR. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics : a Review Publication of the Radiological Society of North America, Inc. 24: 105-19. PMID 14730040 DOI: 10.1148/Rg.241035058 |
0.427 |
|
| 2002 |
Hasegawa BH, Wong KH, Iwata K, Barber WC, Hwang AB, Sakdinawat AE, Ramaswamy M, Price DC, Hawkins RA. Dual-modality imaging of cancer with SPECT/CT. Technology in Cancer Research & Treatment. 1: 449-58. PMID 12625772 DOI: 10.1177/153303460200100605 |
0.4 |
|
| 2002 |
Pham KH, Ramaswamy MR, Hawkins RA. Advances in positron emission tomography imaging for the GI tract. Gastrointestinal Endoscopy. 55: S53-63. PMID 12024124 DOI: 10.1067/Mge.2002.124741 |
0.372 |
|
| 2001 |
Knowlton RC, Laxer KD, Klein G, Sawrie S, Ende G, Hawkins RA, Aassar OS, Soohoo K, Wong S, Barbaro N. In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy. Neurology. 57: 1184-90. PMID 11591833 DOI: 10.1212/Wnl.57.7.1184 |
0.302 |
|
| 2000 |
Schneider DB, Clary-Macy C, Challa S, Sasse KC, Merrick SH, Hawkins R, Caputo G, Jablons D. Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma. The Journal of Thoracic and Cardiovascular Surgery. 120: 128-133. PMID 10884665 DOI: 10.1067/Mtc.2000.106529 |
0.422 |
|
| 1999 |
Aassar OS, Fischbein NJ, Caputo GR, Kaplan MJ, Prince DC, Singer MI, Dillon WP, Hawkins RA. Metastatic head and neck cancer: Role and usefulness of FDG PET in locating occult primary tumors Radiology. 210: 177-181. PMID 9885604 DOI: 10.1148/Radiology.210.1.R99Ja48177 |
0.437 |
|
| 1997 |
Knowlton RC, Laxer KD, Ende G, Hawkins RA, Wong ST, Matson GB, Rowley HA, Fein G, Weiner MW. Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy. Annals of Neurology. 42: 829-37. PMID 9403474 DOI: 10.1002/Ana.410420603 |
0.408 |
|
| 1997 |
Nelson SJ, Huhn S, Vigneron DB, Day MR, Wald LL, Prados M, Chang S, Gutin PH, Sneed PK, Verhey L, Hawkins RA, Dillon WP. Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: presentation of a detailed case study. Journal of Magnetic Resonance Imaging : Jmri. 7: 1146-52. PMID 9400861 DOI: 10.1002/Jmri.1880070630 |
0.417 |
|
| 1997 |
Nelson SJ, Day MR, Buffone PJ, Wald LL, Budinger TF, Hawkins R, Dillon WP, Huhn S, Prados MD, Chang S, Vigneron DB. Alignment of volume MR images and high resolution [18F]fluorodeoxyglucose PET images for the evaluation of patients with brain tumors. Journal of Computer Assisted Tomography. 21: 183-91. PMID 9071283 DOI: 10.1097/00004728-199703000-00004 |
0.421 |
|
| 1996 |
Wong STC, Knowlton RC, Hawkins RA, Laxer KD. Multimodal image fusion for noninvasive epilepsy surgery planning Ieee Computer Graphics and Applications. 16: 30-38. DOI: 10.1109/38.481564 |
0.318 |
|
| 1994 |
Hawkins RA, Hoh CK. PET FDG studies in oncology Nuclear Medicine and Biology. 21: 739-747. PMID 9241650 DOI: 10.1016/0969-8051(94)90045-0 |
0.434 |
|
| 1994 |
Tse N, Hoh C, Hawkins R, Phelps M, Glaspy J. Positron emission tomography diagnosis of pulmonary metastases in osteogenic sarcoma. American Journal of Clinical Oncology. 17: 22-5. PMID 8311003 DOI: 10.1097/00000421-199402000-00006 |
0.386 |
|
| 1994 |
Carli MFD, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, Czernin J, Rokhsar S, Stevenson LW, Laks H, Hawkins R, Schelbert HR, Phelps ME, Maddahi J. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction American Journal of Cardiology. 73: 527-533. PMID 8147295 DOI: 10.1016/0002-9149(94)90327-1 |
0.343 |
|
| 1994 |
Hoh CK, Dahlbom M, Hawkins RA, Glaspy JA, Yao WJ, Lee SJ, Maddahi J, Phelps ME. Basic principles of positron emission tomography in oncology: quantitation and whole body techniques. Wiener Klinische Wochenschrift. 106: 496-504. PMID 7941598 |
0.33 |
|
| 1994 |
Black KL, Emerick T, Hoh C, Hawkins RA, Mazziotta J, Becker DP. Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence. Neurological Research. 16: 93-6. PMID 7914007 DOI: 10.1080/01616412.1994.11740201 |
0.301 |
|
| 1993 |
Hoh CK, Hawkins RA, Dahlbom M, Glaspy JA, Seeger LL, Choi Y, Schiepers CW, Huang SC, Satyamurthy N, Barrio JR, Phelps ME. Whole body skeletal imaging with [18f]fluoride ion and pet Journal of Computer Assisted Tomography. 17: 34-41. PMID 8419436 DOI: 10.1097/00004728-199301000-00005 |
0.395 |
|
| 1993 |
Rege SD, Hoh CK, Glaspy JA, Aberle DR, Dahlbom M, Razavi MK, Phelps ME, Hawkins RA. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Cancer. 72: 82-90. PMID 8389668 DOI: 10.1002/1097-0142(19930701)72:1<82::Aid-Cncr2820720117>3.0.Co;2-3 |
0.363 |
|
| 1993 |
Hoh CK, Hawkins RA, Glaspy JA, Dahlbom M, Tse NY, Hoffman EJ, Schiepers C, Choi Y, Rege S, Nitzsche E. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose. Journal of Computer Assisted Tomography. 17: 582-9. PMID 8331230 DOI: 10.1097/00004728-199307000-00012 |
0.342 |
|
| 1992 |
Tse NY, Hoh CK, Hawkins RA, Zinner MJ, Dahlbom M, Choi Y, Maddahi J, Brunicardi FC, Phelps ME, Glaspy JA. The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease. Annals of Surgery. 216: 27-34. PMID 1632699 DOI: 10.1097/00000658-199207000-00005 |
0.378 |
|
| 1992 |
Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Ho C, Ward PH. Positron emission tomography: A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy Laryngoscope. 102: 281-288. PMID 1545657 |
0.32 |
|
| 1992 |
Messa C, Choi Y, Hoh CK, Jacobs EL, Glaspy JA, Rege S, Nitzsche E, Huang SC, Phelps ME, Hawkins RA. Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET. Journal of Computer Assisted Tomography. 16: 684-9. PMID 1522257 DOI: 10.1097/00004728-199209000-00003 |
0.379 |
|
| 1992 |
Hawkins RA, Hoh C, Glaspy J, Choi Y, Dahlbom M, Rege S, Messa C, Nietszche E, Hoffman E, Seeger L. The role of positron emission tomography in oncology and other whole-body applications. Seminars in Nuclear Medicine. 22: 268-84. PMID 1439872 DOI: 10.1016/S0001-2998(05)80121-7 |
0.391 |
|
| 1989 |
Guze BH, Hawkins RA. Utility of the SPECT Tc-99m labeled RBC blood pool scan in the detection of hepatic hemangiomas. Clinical Nuclear Medicine. 14: 817-818. PMID 2598553 DOI: 10.1097/00003072-198911000-00007 |
0.319 |
|
| 1988 |
Guze BH, Hawkins R. The utility of SPECT liver-spleen imaging in the evaluation of a possible accessory spleen. Clinical Nuclear Medicine. 13: 496-497. PMID 3262476 DOI: 10.1097/00003072-198807000-00004 |
0.341 |
|
| 1986 |
Hawkins RA, Barrio JR, Phelps ME, Huang S, Bahn M, Satyamurthy N, Luxen A, Keen R, Nissenson C, Hoffman JM, John C. A STUDY OF PRE- AND POSTSYNAPTIC ACTIONS OF THE DOPAMINERGIC SYSTEM WITH PET. Clinical Nuclear Medicine. 11: P11. DOI: 10.1097/00003072-198609001-00006 |
0.357 |
|
| Show low-probability matches. |